Very early invasive strategy in higher risk non-ST-elevation acute coronary syndrome: the RAPID NSTEMI trial
Thomas A Kite(University of Leicester), Anthony Gershlick, Gerry P McCann(University of Leicester), Andrew Ladwiniec(University Hospitals of Leicester NHS Trust), Shaun Barber(University of Leicester), Nick Curzen(University Hospital Southampton NHS Foundation Trust), Marcus Flather(Norfolk and Norwich University Hospital), Chris P Gale(University of Leeds), Colin Berry(University of Glasgow), Peter O’Kane(Royal Bournemouth Hospital), Sohail Q. Khan(Queen Elizabeth Hospital Birmingham), Ghazala Waheed(University of Leicester), Brijesh Anantharam(Portsmouth Hospitals NHS Trust), Adrian Banning(John Radcliffe Hospital), Roby Rakhit(Royal Free London NHS Foundation Trust), Ranjit More(University of Liverpool), John P. Greenwood(University of Leeds), Alexander Chase(Morriston Hospital), Simon Hetherington(Kettering General Hospital)
Cited by 14
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
2023 ESC Guidelines for the management of cardiomyopathies
|European Heart Journal|2023|2.3k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k